[Dubai, UAE] – Goldsite, a key player in the laboratory diagnostics market, made a strong impression at the recent Medlab Middle East 2023 for the first time in 3 years, after the unprecedented COVID-19 pandemic era since 2020.
On Feburary 6th, the first day of Medlab Middle East 2023, the booth of Goldsite was heated with visitors who are impressed by the exhibited innovative product portfolio. Attendees were wowed by the advanced technology and unique features some flagship products, like HbA1c solutions, both HPLC benchtop HbA1c Analyzer GSH-60 and POCT HbA1c Anazlyer A1c Go, both of which offers fast and accurate deliver of HbA1c test result, the known marker for monitoring blood glucose level for diabetes patients.
The GSH-60 was met with great enthusiasm by visitors, This instrument is designed to meet the growing demands of the chronic disease diabetes management, providing the laboratory with a tool for effectively assess the patients' status with diabtes.
"It was an honor to showcase our new HbA1c solutions at the Medlab after 3 years," said Joan Huang, the director of Goldsite Overseas Sales Dept. "We are thrilled with the positive response we received from attendees and are confident that our HbA1c solution will meet our customer's need in different levels. Goldsite will be always fullfill its commitment to delivering the high quality medical diagnostics products in the industry."
GOLDSITE DIGANOSTICS INC. is a leading manufacturer of IVD products dedicated to healthcare sector. With over 23 years expertise in the IVD industry, Goldsite has established itself as a trusted partner since 1999. With a team of experts in the field of diagnostics technology and a passion for improving healthcare, we strive to bring cutting-edge products to market that meet the evolving needs of health providers and patients. Engaged in R&D, manufacturing and marketing of clinical laboratory devices and reagents, Goldsite have a portfolio of products covers specific protein, chemistry, chemiluminescence and POCT platform, as well as associated reagents. All products are live up to global standard with CE marking and have been exported into more than 80+ countries.
Our vision is to deliver state-of-art solutions that enhance patient care and improve health outcomes. We are dedicated to providing healthcare professionals with the tools they need to deliver accurate and reliable diagnoses, while also making medical diagnostics more accessible and affordable for all. We aim to make a positive impact on global health and well-being.
For more information, stay connected with us on our social media platforms to keep up-to-date with the latest industry news and trends, as well as insights and updates from our company. Follow us on Facebook, LinkedIn, YouTube, Twitter to be the first to know about our new products and services, events, and exciting R&D updates.
Link to our social media platform: